Pfizer asks Swiss OK for COVID-19 vaccine for children 12 to 15
ZURICH, May 7 (Reuters) - Pfizer has sought Swiss regulatory approval for its COVID-19 vaccine in children aged 12 to 15, regulator Swissmedic said on Friday. It is currently authorised…
